The Future of Biopharmaceutical Contract Manufacturing in Europe - What Underpins the Success of CMOs?

The Future of Biopharmaceutical Contract Manufacturing in Europe - What Underpins the Success of CMOs?

European Biopharmaceutical Contract Manufacturing Market

RELEASE DATE
09-Apr-2013
REGION
Global
Research Code: 9837-00-31-00-00
SKU: LS00063-GL-MR_16904
AvailableYesPDF Download
$1,500.00
In stock
SKU
LS00063-GL-MR_16904
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This market insight provides an in-depth understanding of the key drivers and challenges that impact the growth of the European biopharmceutical contract manufacturing market. An overview of the key biologics in various phases of clinical pipeline as well as the manufacturing capacity demand forecasts have been provided. A snapshot of the competitive structure and the future directions and trends in the European biopharmaceutical contract manufacturing market have been discussed.

Table of Contents

Related Research
This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's in-store pharmacies and clinics, and Thermo Fisher Scientific's acquisition of Alfa Aesar.
More Information
No Index Yes
Podcast No
Author Aiswariya Chidambaram
WIP Number 9837-00-31-00-00
Is Prebook No